CIK 0001817229
- Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811591163
- Phone
- +1 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- 4 Grant or award President and CEO acquired 128,750 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 54,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 45,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 47,750 shares (grant or award)
- 4 Grant or award Director acquired 11,627,907 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 172,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 76,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 86,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 11 · 212 filings